Skip to main navigation Skip to search Skip to main content

GLP1 agonists in treating neurodegeneration and addictions

Press/Media: Press / Media

Description

An exper interview for the Apteekkari magazine of the The Association of Finnish Pharmacies on the potential of GLP1 agonists as a treatment for neurodegenerative diseases and addictions and the current state of the related research.

Period11 Dec 202416 Jan 2025

Media contributions

2

Media contributions